Thailand Clears the Path for Vitamin Use: Streamlined Approval for Supplements
Thailand’s Food and Drug Administration has cut red tape for vitamin and mineral use in foods, issuing a landmark notice on November 17, 2025, that eliminates redundant safety reviews for approved forms. Companies can now use ingredients listed in Annex 1 for dietary supplements and Annex 2 for general fortified foods without submitting new toxicology data.
The move explicitly allows reference to EU regulations for ingredient validation—a nod to international harmonization. However, strict rules remain for infant formula and medical foods, where composition is tightly controlled.
By aligning with global standards and reducing bureaucratic friction, Thailand aims to boost its nutraceutical industry while ensuring consumer safety. It’s a win for both public health and business efficiency.
2026-09-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Global Countries Impose Tariffs on Chinese Chemical Products
-
Rare Earth and Power: Strategic Probing Beneath the New U.S.–China Trade Framework
-
U.S. Chemical Tariff Deadline Nears as the Industry Faces Cost Repricing and Supply-Chain Adjustment
-
EU Finalizes Anti-Dumping Duties on Chinese Adipic Acid as Chemical Trade Enters a Rule-Intensive Phase
-
EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry
-
China's National Narcotics Control Commission Issues Important Notice: Beware of These 8 Chemicals Being Diverted for Drug Production
-
API Supplier Audits Move to the Center of Pharma Supply Resilience
-
Supplement Recall Puts Nutrition Ingredient Safety Back Under Pressure
-
Chemours Sells Its Former Titanium Dioxide Site in Taiwan: Turning a “White Powder” Factory into “Wind Power Real Estate” for $360 Million—Buying Not Cash, But Breathing Room
-
The “Counter-Wind Ledger” of CHF 11.2 Billion: Sika Barely Grew in 2025—Yet Kept Taking Market Share
Recommend Reading
-
Solvay’s Zhenjiang Plant Expansion Goes Online, Doubling Electronic-Grade Hydrogen Peroxide Output to Support Semiconductor Advancements
-
ExxonMobil “Hits the Brakes”: Industrial Fractures Under the EU’s Chemical Recycling Policy Reef
-
Sun Pharma’s Winning Formula: Precision Over Expansion
-
Sun Pharma’s Secret Sauce: Solve the Specific, Win the Market
-
The Oral GLP-1 Cage Match: Orforglipron vs Rybelsus
-
China’s EVA Market Has Entered a Downward Trend Since May
-
Insufficient Demand for Cyclohexane in China, Prices Narrowly Fluctuate
-
Business Society’s Market Outlook for Cyclohexanone on August 12, 2026: Price Trends Clearly Upward
-
Chinese Ammonium Sulfate Market Stops Rising and Falls (5.14-5.21)
-
Business Society’s August 13, 2026 Cyclohexanone Market Outlook: Clearly Upward Trend